Relief Therapeutics Holding AG Stock Other OTC
Equities
RLFTF
CH0100191136
Biotechnology & Medical Research
Sales 2022 | 6.08M 6.78M | Sales 2023 | 6.03M 6.73M | Capitalization | 24.96M 27.83M |
---|---|---|---|---|---|
Net income 2022 | -50M -55.76M | Net income 2023 | -98M -109M | EV / Sales 2022 | 19.3 x |
Net cash position 2022 | 14.89M 16.61M | Net cash position 2023 | 10.25M 11.44M | EV / Sales 2023 | 2.44 x |
P/E ratio 2022 |
-2.5
x | P/E ratio 2023 |
-0.24
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 65.87% |
Managers | Title | Age | Since |
---|---|---|---|
Ram Selvaraju
CHM | Chairman | 45 | 16-05-24 |
Michelle Lock
BRD | Director/Board Member | 55 | 22-01-27 |
Anthony M. Kim
PRN | Corporate Officer/Principal | - | 21-11-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Ram Selvaraju
CHM | Chairman | 45 | 16-05-24 |
Paolo Galfetti
PRN | Corporate Officer/Principal | 59 | 21-05-26 |
Michelle Lock
BRD | Director/Board Member | 55 | 22-01-27 |
1st Jan change | Capi. | |
---|---|---|
+48.60% | 57.87B | |
+41.65% | 40.25B | |
-6.70% | 39.94B | |
-5.96% | 28.54B | |
+13.01% | 26.4B | |
-20.03% | 19.33B | |
+31.63% | 12.4B | |
+0.48% | 12.23B | |
+25.11% | 12.2B |